Back to All Research Reports The Biosynthesis Maverick: Turning Cannabis Compounds Into Cash Piles Amyris Inc. (Nasdaq: AMRS) caught the attention of the Bill and Melinda Gates Foundation because of its ability to cheaply manufacture the main drug that now fights malaria. You must subscribe to Danny Brody’s Cannabis Inner Circle to view this content. To learn more and access special member pricing contact our VIP team at 1-866-298-7257. Sign In Enter your details below. USERNAME OR EMAIL PASSWORD Remember Me Forgot Password?